| | propyl-delta(8)-tetrahydrocannabinol Basic information |
| Product Name: | propyl-delta(8)-tetrahydrocannabinol | | Synonyms: | propyl-delta(8)-tetrahydrocannabinol;6H-Dibenzo[b,d]pyran-1-ol, 6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-propyl-, (6aR,10aR)-;Δ8-Tetrahydrocannabivarin;Δ8-Tetrahydrocannabivarin (exempt preparation) | | CAS: | 31262-38-1 | | MF: | C19H26O2 | | MW: | 286.41 | | EINECS: | | | Product Categories: | | | Mol File: | 31262-38-1.mol |  |
| | propyl-delta(8)-tetrahydrocannabinol Chemical Properties |
| Boiling point | 353.2±42.0 °C(Predicted) | | density | 1.034±0.06 g/cm3(Predicted) | | storage temp. | -65 to -96°C | | pka | 9.81±0.60(Predicted) |
| | propyl-delta(8)-tetrahydrocannabinol Usage And Synthesis |
| Description | Δ8-Tetrahydrocannabivarin is an analytical reference standard categorized as a cannabinoid.1 Δ8-Tetrahydrocannabivarin is regulated as a Schedule I compound in the United States. Δ8-Tetrahydrocannabivarin is provided as a DEA exempt preparation. This product is intended for research and forensic applications. | | References | 1. Bátkai, S., Mukhopadhyay, P., Horváth, B., et al. Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors Br. J. Pharmacol. 165(8),2450-2461(2012). |
| | propyl-delta(8)-tetrahydrocannabinol Preparation Products And Raw materials |
|